Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.5700 (5.27%) ($13.8300 - $14.6700) on Tue. Jun. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.17% (three month average) | RSI | 78 | Latest Price | $14.5700(5.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 18.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.585% in a week (0% probabilities). VIXM(-32%) VXX(-27%) XLC(-9%) UUP(-9%) UNG(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.585% (StdDev 7.17%) | Hourly BBV | 0 () | Intraday Trend | 3.9% | | | |
|
5 Day Moving Average | $13.77(5.81%) | 10 Day Moving Average | $12.58(15.82%) | 20 Day Moving Average | $11.33(28.6%) | To recent high | -2.4% | To recent low | 93.5% | Market Cap | $1.083b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |